|
| Home : Cancer Immunotherapy Market to grow by USD 74.45 bn at a CAGR of 14.67% | Evolving Opportunities with Amgen Inc., Bayer AG & Bristol-Myers Squibb Co. | 17000+ Technavio Reports |
|
Dec 14
2021 |
Cancer Immunotherapy Market to grow by USD 74.45 bn at a CAGR of 14.67% | Evolving Opportunities with Amgen Inc., Bayer AG & Bristol-Myers Squibb Co. | 17000+ Technavio Reports |
|
NEW YORK, Dec. 14, 2021 /PRNewswire/ -- Technavio's latest research report on the Cancer Immunotherapy Market offers a comprehensive analysis of new product launches, the latest trends, drivers, and challenges. 37% of the market's growth will originate from North America during the... |
|
|
|
| Source:https://www.prnewswire.com:443/news-releases/cancer-immunotherapy-market-to-grow-by-usd-74-45-bn-at-a-cagr-of-14-67--evolving-opportunities-with-amgen-inc-bayer-ag--bristol-myers-squibb-co--17000--technavio-reports-301443177.html |
| |
|
Related News
|
» Capitalab Completes Second EURO STOXX 50 Equity Derivatives Compression Cycle Offsetting $6 Billion Notional
» Pioneering New EVs Lead Hyundai Motor Group's Record Number of Global Awards in 2021
|
|
|
